EVOFEM BIOSCIENCES, INC. Total Liabilities and Equity
EVOFEM BIOSCIENCES, INC. (EVFM) had Total Liabilities and Equity of $7.52 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-14
- 2026-06-30: Liabilities and Equity $7.52M.
- 2026-03-31: Liabilities and Equity $7.44M.
- 2025-12-31: Liabilities and Equity $20.27M.
- 2025-09-30: Liabilities and Equity $13.81M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $7.52M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $7.44M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $20.27M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $13.81M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $14.38M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $12.88M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $23.79M 10-K · filed 2026-03-11 | |
| 2024-09-30 | $23.94M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $8.55M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $8.22M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $10.55M 10-K · filed 2025-03-24 | |
| 2023-09-30 | $13.32M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $14.07M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $26.03M 10-Q · filed 2023-06-16 | |
| 2022-12-31 | $25.16M 10-K · filed 2024-03-27 | |
| 2022-09-30 | $42.28M 10-Q · filed 2023-01-06 | |
| 2022-06-30 | $53.47M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $34.57M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $42.51M 10-K · filed 2023-04-27 | |
| 2021-09-30 | $67.43M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $108.75M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $93.46M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $109.97M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $112.33M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $135.06M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $15.64M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $28.30M 10-K · filed 2021-03-04 | |
| 2019-09-30 | $38.99M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $54.41M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $3.23M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $4.01M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $15.03M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $26.17M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $8.99M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $3.95M 10-K · filed 2019-03-01 | $4.12M 10-K · filed 2018-02-26 |
| 2017-09-30 | $6.25M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $8.21M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $10.73M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $14.37M 8-K/A · filed 2018-04-06 | $12.82M 10-K · filed 2017-03-23 |
| 2016-09-30 | $15.21M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $22.58M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $25.53M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $40.11M 10-K · filed 2017-03-23 | |
| 2015-09-30 | $52.67M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $64.19M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $71.92M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $76.90M 10-K · filed 2016-03-29 |